Discontinuation report URSO

Last updated on 2023-01-06 History
Report ID 177861
Drug Identification Number 02238984
Brand name URSO
Common or Proper name Urso ( ursodiol) tablets
Company Name APTALIS PHARMA CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) URSODIOL
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100s
ATC code A05AA
ATC description BILE THERAPY
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-12-07
Actual discontinuation date 2022-12-07
Remaining supply date 2022-12-07
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-12-10 English Compare
v2 2022-12-10 French Compare
v3 2023-01-06 English Compare
v4 2023-01-06 French Compare

Showing 1 to 4 of 4